British Journal of Haematology · 1994 · 41 citations · 16 references
Life SciencesHematologyImmunologyImmunogeneticsTransfusion MedicineTransplant ImmunologyGraft-versus-host DiseaseHistocompatibilityTransfusion ReactionsTransfusion TherapyTransplant ImmunotherapyTransplantation ImmunogeneticsDonor Chimerism Supportive PharmacotherapyGraft Versus Host Disease ModulationGraft-versus-host Disease ImmunogeneticsGraft-versus-host Disease PathophysiologyPeripheral Blood Lymphocyte AnalysisTransfusion-associated Graft-versus-host Disease
We present an immunocompetent patient with transfusion-associated graft-versus-host disease (GVHD), in which chimaerism of peripheral blood lymphocytes was demonstrated by analysis of a highly polymorphic genome. The patient was treated successfully with anti-CD3 monoclonal antibody, OKT3 and cyclosporin A. Although it is undoubtedly important to prevent transfusion-associated GVHD by irradiation of cellular blood components, intensive therapy with OKT3 and cyclosporin A in the early phase of onset may be effective for treatment of this potentially fatal condition. The mechanism of the effectiveness of this treatment for transfusion-associated GVHD is discussed.
16
In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia
RA Miller, DG Maloney, J McKillop et al. · Blood · 1981 · 258 citations · Full text
Pharmacy, Immunology, Oncology +16